SPACs Opioids and COVID Ensysce Biosciences Making Virtual History

SPACs, Opioids, and COVID: Ensysce Biosciences Making "Virtual" History
By Louis Garguilo, Chief Editor, Outsourced Pharma
If Ensysce Biosciences were a ball of yarn, we’d be unwinding it for hundreds of miles from its location in La Jolla, California.
We’d unravel:
Clinical candidate for one of the worst words in the drug industry: opioids
An all-outsourced model and a mere five employees
One of the first biotechs to go public via a SPAC (special purpose acquisition company)
The serendipitous discovery of an in-house material that works against COVID-19
Could Lynn Kirkpatrick have picked a more challenging biopharma to join as CEO?

Related Keywords

California ,United States ,La Jolla ,Louis Garguilo ,Jeff Millard ,Jeffrey Millard ,Lynn Kirkpatrick ,Ensysce Biosciences , ,Chief Editor ,The Right ,Chief Operating Officer Jeffrey ,கலிஃபோர்னியா ,ஒன்றுபட்டது மாநிலங்களில் ,லா ஜொல்லா ,லின் கர்க்‌ப்யாட்ரிக் ,தலைமை ஆசிரியர் ,தி சரி ,தலைமை இயங்குகிறது அதிகாரி ஜெஃப்ரி ,